

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | histamine transport (GO:0051608) | 6.55732612 |
| 2 | organic cation transport (GO:0015695) | 5.19431216 |
| 3 | meiotic chromosome segregation (GO:0045132) | 5.01099201 |
| 4 | resolution of meiotic recombination intermediates (GO:0000712) | 4.47516059 |
| 5 | neurotransmitter biosynthetic process (GO:0042136) | 4.43138282 |
| 6 | positive regulation of meiosis (GO:0045836) | 4.35846474 |
| 7 | exogenous drug catabolic process (GO:0042738) | 4.34328227 |
| 8 | neurotransmitter metabolic process (GO:0042133) | 4.30536156 |
| 9 | negative regulation of telomere maintenance (GO:0032205) | 4.28093541 |
| 10 | positive regulation of mast cell activation (GO:0033005) | 4.27586443 |
| 11 | regulation of activation of Janus kinase activity (GO:0010533) | 4.21961118 |
| 12 | negative regulation of mast cell activation (GO:0033004) | 4.20422913 |
| 13 | behavioral response to nicotine (GO:0035095) | 4.18116363 |
| 14 | drug transmembrane transport (GO:0006855) | 4.16631312 |
| 15 | positive regulation of meiotic cell cycle (GO:0051446) | 4.00480971 |
| 16 | azole transport (GO:0045117) | 3.92252550 |
| 17 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.75831656 |
| 18 | quaternary ammonium group transport (GO:0015697) | 3.58477131 |
| 19 | regulation of T cell tolerance induction (GO:0002664) | 3.58453625 |
| 20 | regulation of memory T cell differentiation (GO:0043380) | 3.57073239 |
| 21 | tooth mineralization (GO:0034505) | 3.56825438 |
| 22 | regulation of mast cell activation (GO:0033003) | 3.52447464 |
| 23 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.51101210 |
| 24 | positive regulation of defense response to virus by host (GO:0002230) | 3.45899034 |
| 25 | rRNA methylation (GO:0031167) | 3.43359030 |
| 26 | reciprocal DNA recombination (GO:0035825) | 3.42725545 |
| 27 | reciprocal meiotic recombination (GO:0007131) | 3.42725545 |
| 28 | centriole replication (GO:0007099) | 3.40871603 |
| 29 | rRNA catabolic process (GO:0016075) | 3.37181309 |
| 30 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.34490142 |
| 31 | regulation of T cell cytokine production (GO:0002724) | 3.30291495 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23268554 |
| 33 | secretory granule organization (GO:0033363) | 3.22237848 |
| 34 | regulation of tolerance induction (GO:0002643) | 3.21284779 |
| 35 | positive regulation of histone deacetylation (GO:0031065) | 3.20701259 |
| 36 | drug catabolic process (GO:0042737) | 3.19706655 |
| 37 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.19480563 |
| 38 | DNA deamination (GO:0045006) | 3.15875871 |
| 39 | regulation of chronic inflammatory response (GO:0002676) | 3.14731346 |
| 40 | regulation of glucokinase activity (GO:0033131) | 3.13173002 |
| 41 | regulation of hexokinase activity (GO:1903299) | 3.13173002 |
| 42 | fatty acid elongation (GO:0030497) | 3.10363068 |
| 43 | synaptonemal complex assembly (GO:0007130) | 3.10285619 |
| 44 | sequestering of actin monomers (GO:0042989) | 3.08616499 |
| 45 | neutrophil activation (GO:0042119) | 3.02532541 |
| 46 | regulation of meiosis I (GO:0060631) | 3.01548063 |
| 47 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.01449498 |
| 48 | regulation of defense response to virus by host (GO:0050691) | 2.99750166 |
| 49 | lysosome localization (GO:0032418) | 2.98139801 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.96314784 |
| 51 | metallo-sulfur cluster assembly (GO:0031163) | 2.94608042 |
| 52 | iron-sulfur cluster assembly (GO:0016226) | 2.94608042 |
| 53 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.92626834 |
| 54 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92294900 |
| 55 | drug transport (GO:0015893) | 2.92205846 |
| 56 | activated T cell proliferation (GO:0050798) | 2.91492528 |
| 57 | positive regulation of mast cell degranulation (GO:0043306) | 2.91390390 |
| 58 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.91390390 |
| 59 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.88006154 |
| 60 | rRNA modification (GO:0000154) | 2.86790702 |
| 61 | cellular response to exogenous dsRNA (GO:0071360) | 2.85407442 |
| 62 | regulation of telomere maintenance (GO:0032204) | 2.85016679 |
| 63 | cellular extravasation (GO:0045123) | 2.82892622 |
| 64 | negative regulation of growth of symbiont in host (GO:0044130) | 2.80638834 |
| 65 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.80638834 |
| 66 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.80638834 |
| 67 | regulation of growth of symbiont in host (GO:0044126) | 2.80638834 |
| 68 | synaptonemal complex organization (GO:0070193) | 2.79607051 |
| 69 | regulation of interleukin-8 secretion (GO:2000482) | 2.77507250 |
| 70 | histone H3-K36 demethylation (GO:0070544) | 2.72027384 |
| 71 | GPI anchor metabolic process (GO:0006505) | 2.70071961 |
| 72 | cytidine deamination (GO:0009972) | 2.68698302 |
| 73 | cytidine metabolic process (GO:0046087) | 2.68698302 |
| 74 | cytidine catabolic process (GO:0006216) | 2.68698302 |
| 75 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.68416971 |
| 76 | cornea development in camera-type eye (GO:0061303) | 2.67439438 |
| 77 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.67405637 |
| 78 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.67094783 |
| 79 | regulation of T cell mediated immunity (GO:0002709) | 2.65248375 |
| 80 | DNA dealkylation (GO:0035510) | 2.64867725 |
| 81 | imidazole-containing compound metabolic process (GO:0052803) | 2.64550139 |
| 82 | positive regulation of T cell chemotaxis (GO:0010820) | 2.63010717 |
| 83 | regulation of T cell chemotaxis (GO:0010819) | 2.63010717 |
| 84 | piRNA metabolic process (GO:0034587) | 2.60746395 |
| 85 | chromosome organization involved in meiosis (GO:0070192) | 2.59685114 |
| 86 | response to pheromone (GO:0019236) | 2.56890209 |
| 87 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.56589053 |
| 88 | bone trabecula formation (GO:0060346) | 2.56378586 |
| 89 | base-excision repair, AP site formation (GO:0006285) | 2.55657386 |
| 90 | positive regulation of protein deacetylation (GO:0090312) | 2.54973552 |
| 91 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.54648205 |
| 92 | fucose catabolic process (GO:0019317) | 2.54344622 |
| 93 | L-fucose metabolic process (GO:0042354) | 2.54344622 |
| 94 | L-fucose catabolic process (GO:0042355) | 2.54344622 |
| 95 | positive regulation of hair cycle (GO:0042635) | 2.53625229 |
| 96 | positive regulation of hair follicle development (GO:0051798) | 2.53625229 |
| 97 | natural killer cell activation involved in immune response (GO:0002323) | 2.53405731 |
| 98 | protein polyglutamylation (GO:0018095) | 2.51342363 |
| 99 | centriole assembly (GO:0098534) | 2.50671410 |
| 100 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.49747228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.45793476 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 4.43443821 |
| 3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.56212329 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.39195526 |
| 5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.63899018 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.52718121 |
| 7 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.37366528 |
| 8 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.25276173 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.96907843 |
| 10 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.96080499 |
| 11 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.95685351 |
| 12 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.94563526 |
| 13 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.90821835 |
| 14 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.90172464 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89124909 |
| 16 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.85334672 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 1.85290076 |
| 18 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.82489142 |
| 19 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.79134099 |
| 20 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.75499356 |
| 21 | EWS_26573619_Chip-Seq_HEK293_Human | 1.74142399 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70216484 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.70132814 |
| 24 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.65255841 |
| 25 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64991235 |
| 26 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.62971344 |
| 27 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.61341224 |
| 28 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.59323176 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.59157848 |
| 30 | GATA3_26560356_Chip-Seq_TH2_Human | 1.58234319 |
| 31 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.54545689 |
| 32 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.54545689 |
| 33 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.46729627 |
| 34 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.43916645 |
| 35 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.43437687 |
| 36 | FUS_26573619_Chip-Seq_HEK293_Human | 1.41765741 |
| 37 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.37401775 |
| 38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.36944556 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36115108 |
| 40 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.34325270 |
| 41 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.34242508 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.34050979 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33882789 |
| 44 | AR_20517297_ChIP-Seq_VCAP_Human | 1.32886394 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.32824530 |
| 46 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.32324870 |
| 47 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31369351 |
| 48 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.30260672 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29208256 |
| 50 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.27789904 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24735483 |
| 52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.23259788 |
| 53 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.23210827 |
| 54 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.23210827 |
| 55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.22494649 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21642091 |
| 57 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20835114 |
| 58 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.20818701 |
| 59 | GATA3_26560356_Chip-Seq_TH1_Human | 1.20625926 |
| 60 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20148226 |
| 61 | ERA_21632823_ChIP-Seq_H3396_Human | 1.19334574 |
| 62 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.19199572 |
| 63 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17821753 |
| 64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16442560 |
| 65 | NCOR_22424771_ChIP-Seq_293T_Human | 1.16004008 |
| 66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15573676 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14597525 |
| 68 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.14212131 |
| 69 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.12270445 |
| 70 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.10687724 |
| 71 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.09790760 |
| 72 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.09762672 |
| 73 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09368014 |
| 74 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07230614 |
| 75 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.06279542 |
| 76 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.05703051 |
| 77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05589972 |
| 78 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.03973510 |
| 79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03569602 |
| 80 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.03541723 |
| 81 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.03293295 |
| 82 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03052583 |
| 83 | MYB_26560356_Chip-Seq_TH1_Human | 1.02623944 |
| 84 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02604006 |
| 85 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.02250705 |
| 86 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02189668 |
| 87 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.02142473 |
| 88 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01639440 |
| 89 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.99681280 |
| 90 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99605289 |
| 91 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99226616 |
| 92 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.98851404 |
| 93 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.98570951 |
| 94 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.98495054 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98015517 |
| 96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98015517 |
| 97 | P300_27268052_Chip-Seq_Bcells_Human | 0.97593148 |
| 98 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97400989 |
| 99 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.96384862 |
| 100 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95610855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.00829066 |
| 2 | MP0003646_muscle_fatigue | 2.95724154 |
| 3 | MP0008877_abnormal_DNA_methylation | 2.90205158 |
| 4 | MP0000372_irregular_coat_pigmentation | 2.89499348 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.68406254 |
| 6 | MP0005671_abnormal_response_to | 2.46814445 |
| 7 | MP0002102_abnormal_ear_morphology | 2.44864231 |
| 8 | MP0005075_abnormal_melanosome_morpholog | 2.43555120 |
| 9 | MP0005645_abnormal_hypothalamus_physiol | 2.35436275 |
| 10 | MP0001873_stomach_inflammation | 2.24055267 |
| 11 | MP0008872_abnormal_physiological_respon | 2.19493108 |
| 12 | MP0008057_abnormal_DNA_replication | 2.17770579 |
| 13 | MP0001790_abnormal_immune_system | 2.14175318 |
| 14 | MP0005387_immune_system_phenotype | 2.14175318 |
| 15 | MP0001529_abnormal_vocalization | 2.08242776 |
| 16 | MP0003787_abnormal_imprinting | 2.04214197 |
| 17 | MP0004043_abnormal_pH_regulation | 2.03959762 |
| 18 | MP0002160_abnormal_reproductive_system | 2.02636247 |
| 19 | MP0001919_abnormal_reproductive_system | 2.00895499 |
| 20 | MP0001986_abnormal_taste_sensitivity | 1.95600559 |
| 21 | MP0001800_abnormal_humoral_immune | 1.88538081 |
| 22 | MP0008995_early_reproductive_senescence | 1.82255722 |
| 23 | MP0005389_reproductive_system_phenotype | 1.81133543 |
| 24 | MP0005410_abnormal_fertilization | 1.78739390 |
| 25 | MP0002735_abnormal_chemical_nociception | 1.72935146 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.69864355 |
| 27 | MP0005085_abnormal_gallbladder_physiolo | 1.68093542 |
| 28 | MP0008058_abnormal_DNA_repair | 1.66595408 |
| 29 | MP0003195_calcinosis | 1.56898128 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.54229823 |
| 31 | MP0002723_abnormal_immune_serum | 1.52999497 |
| 32 | MP0004142_abnormal_muscle_tone | 1.48895607 |
| 33 | MP0005167_abnormal_blood-brain_barrier | 1.48634691 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.46635797 |
| 35 | MP0001819_abnormal_immune_cell | 1.45282181 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.42848952 |
| 37 | MP0002822_catalepsy | 1.38918398 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.37388362 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.29859839 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.26996801 |
| 41 | MP0009785_altered_susceptibility_to | 1.26975674 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.26355700 |
| 43 | MP0002419_abnormal_innate_immunity | 1.24960191 |
| 44 | MP0004381_abnormal_hair_follicle | 1.23549550 |
| 45 | MP0005000_abnormal_immune_tolerance | 1.23141251 |
| 46 | MP0004742_abnormal_vestibular_system | 1.23058212 |
| 47 | MP0010329_abnormal_lipoprotein_level | 1.20591495 |
| 48 | MP0000015_abnormal_ear_pigmentation | 1.20140891 |
| 49 | MP0006082_CNS_inflammation | 1.18542687 |
| 50 | MP0009764_decreased_sensitivity_to | 1.17417684 |
| 51 | MP0005025_abnormal_response_to | 1.16837465 |
| 52 | MP0000716_abnormal_immune_system | 1.13269443 |
| 53 | MP0003786_premature_aging | 1.12051622 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.11675845 |
| 55 | MP0001764_abnormal_homeostasis | 1.08805410 |
| 56 | MP0005647_abnormal_sex_gland | 1.08318548 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.05912933 |
| 58 | MP0001501_abnormal_sleep_pattern | 1.05281623 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.05052394 |
| 60 | MP0008875_abnormal_xenobiotic_pharmacok | 1.04099386 |
| 61 | MP0002398_abnormal_bone_marrow | 1.04065019 |
| 62 | MP0003698_abnormal_male_reproductive | 1.02278725 |
| 63 | MP0005365_abnormal_bile_salt | 1.01457336 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 1.01393688 |
| 65 | MP0003436_decreased_susceptibility_to | 1.01380344 |
| 66 | MP0005083_abnormal_biliary_tract | 1.00467793 |
| 67 | MP0000685_abnormal_immune_system | 0.99908978 |
| 68 | MP0003252_abnormal_bile_duct | 0.99060965 |
| 69 | MP0005310_abnormal_salivary_gland | 0.98655003 |
| 70 | MP0005174_abnormal_tail_pigmentation | 0.98109201 |
| 71 | MP0002095_abnormal_skin_pigmentation | 0.97805556 |
| 72 | MP0001970_abnormal_pain_threshold | 0.96670356 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 0.96357800 |
| 74 | MP0005266_abnormal_metabolism | 0.95446049 |
| 75 | MP0005253_abnormal_eye_physiology | 0.95027265 |
| 76 | MP0000427_abnormal_hair_cycle | 0.94007747 |
| 77 | MP0002210_abnormal_sex_determination | 0.93926744 |
| 78 | MP0005171_absent_coat_pigmentation | 0.93364122 |
| 79 | MP0001929_abnormal_gametogenesis | 0.93028881 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.91879153 |
| 81 | MP0003136_yellow_coat_color | 0.91009068 |
| 82 | MP0004130_abnormal_muscle_cell | 0.90772848 |
| 83 | MP0001346_abnormal_lacrimal_gland | 0.89878196 |
| 84 | MP0000371_diluted_coat_color | 0.89786570 |
| 85 | MP0002429_abnormal_blood_cell | 0.86789341 |
| 86 | MP0000689_abnormal_spleen_morphology | 0.86328090 |
| 87 | MP0009745_abnormal_behavioral_response | 0.86003217 |
| 88 | MP0002163_abnormal_gland_morphology | 0.85897436 |
| 89 | MP0004484_altered_response_of | 0.82816694 |
| 90 | MP0010386_abnormal_urinary_bladder | 0.79506116 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.79469564 |
| 92 | MP0009115_abnormal_fat_cell | 0.78446502 |
| 93 | MP0006054_spinal_hemorrhage | 0.77915941 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.75944136 |
| 95 | MP0001145_abnormal_male_reproductive | 0.75022506 |
| 96 | MP0002405_respiratory_system_inflammati | 0.74111942 |
| 97 | MP0002272_abnormal_nervous_system | 0.74010370 |
| 98 | MP0005334_abnormal_fat_pad | 0.73675475 |
| 99 | MP0002722_abnormal_immune_system | 0.72094496 |
| 100 | MP0001968_abnormal_touch/_nociception | 0.71708777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Unilateral renal agenesis (HP:0000122) | 5.10652893 |
| 2 | Progressive inability to walk (HP:0002505) | 4.57452610 |
| 3 | Hypoplasia of the fovea (HP:0007750) | 4.41933403 |
| 4 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.41933403 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 4.09811493 |
| 6 | Bilateral microphthalmos (HP:0007633) | 4.05458274 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.83475393 |
| 8 | Abnormality of midbrain morphology (HP:0002418) | 3.53988977 |
| 9 | Molar tooth sign on MRI (HP:0002419) | 3.53988977 |
| 10 | Abnormality of the fovea (HP:0000493) | 3.50225607 |
| 11 | Inability to walk (HP:0002540) | 3.17166811 |
| 12 | Abolished electroretinogram (ERG) (HP:0000550) | 3.12904981 |
| 13 | Abnormality of alanine metabolism (HP:0010916) | 3.12523125 |
| 14 | Hyperalaninemia (HP:0003348) | 3.12523125 |
| 15 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.12523125 |
| 16 | Polydipsia (HP:0001959) | 3.04142948 |
| 17 | Abnormal drinking behavior (HP:0030082) | 3.04142948 |
| 18 | True hermaphroditism (HP:0010459) | 2.99458440 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 2.98377841 |
| 20 | Stomatitis (HP:0010280) | 2.94568720 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 2.93964904 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.93964904 |
| 23 | Attenuation of retinal blood vessels (HP:0007843) | 2.87335365 |
| 24 | Nephronophthisis (HP:0000090) | 2.80977871 |
| 25 | 3-Methylglutaconic aciduria (HP:0003535) | 2.72329316 |
| 26 | Pancreatic cysts (HP:0001737) | 2.72111223 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 2.71497058 |
| 28 | Decreased central vision (HP:0007663) | 2.70285286 |
| 29 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.69192283 |
| 30 | Abnormality of the right ventricle (HP:0001707) | 2.67114791 |
| 31 | Congenital stationary night blindness (HP:0007642) | 2.63529981 |
| 32 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.60330074 |
| 33 | Lissencephaly (HP:0001339) | 2.59006224 |
| 34 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.57865606 |
| 35 | Failure to thrive in infancy (HP:0001531) | 2.56333244 |
| 36 | Chronic hepatic failure (HP:0100626) | 2.55635347 |
| 37 | Aplasia cutis congenita (HP:0001057) | 2.54307362 |
| 38 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.52135975 |
| 39 | Abnormality of the renal medulla (HP:0100957) | 2.43501712 |
| 40 | Polyuria (HP:0000103) | 2.43442685 |
| 41 | Abnormality of T cells (HP:0002843) | 2.40248871 |
| 42 | Abnormality of the renal cortex (HP:0011035) | 2.39436454 |
| 43 | Nephrogenic diabetes insipidus (HP:0009806) | 2.36705341 |
| 44 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.33778546 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.32720643 |
| 46 | Hip dysplasia (HP:0001385) | 2.27247050 |
| 47 | Brushfield spots (HP:0001088) | 2.25455414 |
| 48 | Pancreatic fibrosis (HP:0100732) | 2.23810854 |
| 49 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.22427929 |
| 50 | Encephalitis (HP:0002383) | 2.22260944 |
| 51 | Pustule (HP:0200039) | 2.22135353 |
| 52 | Tubular atrophy (HP:0000092) | 2.21853676 |
| 53 | Aplastic anemia (HP:0001915) | 2.21238669 |
| 54 | Clitoromegaly (HP:0000057) | 2.19773225 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.19081436 |
| 56 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.17984624 |
| 57 | Pendular nystagmus (HP:0012043) | 2.13096508 |
| 58 | Abnormality of the prostate (HP:0008775) | 2.12376243 |
| 59 | IgG deficiency (HP:0004315) | 2.10543194 |
| 60 | Sensorimotor neuropathy (HP:0007141) | 2.08316197 |
| 61 | Duplicated collecting system (HP:0000081) | 2.06276358 |
| 62 | Abnormality of T cell number (HP:0011839) | 2.05620743 |
| 63 | Agammaglobulinemia (HP:0004432) | 2.05057480 |
| 64 | B lymphocytopenia (HP:0010976) | 2.02476792 |
| 65 | Female pseudohermaphroditism (HP:0010458) | 2.00933217 |
| 66 | Hepatitis (HP:0012115) | 2.00263236 |
| 67 | Lower limb hyperreflexia (HP:0002395) | 2.00221212 |
| 68 | Recurrent skin infections (HP:0001581) | 1.95547022 |
| 69 | Abnormality of the renal collecting system (HP:0004742) | 1.93841948 |
| 70 | Abnormal biliary tract physiology (HP:0012439) | 1.93546175 |
| 71 | Bile duct proliferation (HP:0001408) | 1.93546175 |
| 72 | Abnormal urine output (HP:0012590) | 1.90366682 |
| 73 | Recurrent bacterial skin infections (HP:0005406) | 1.89047734 |
| 74 | Hypoproteinemia (HP:0003075) | 1.87387681 |
| 75 | Vacuolated lymphocytes (HP:0001922) | 1.84617162 |
| 76 | Recurrent fungal infections (HP:0002841) | 1.83910609 |
| 77 | CNS hypomyelination (HP:0003429) | 1.83436370 |
| 78 | Abnormality of iron homeostasis (HP:0011031) | 1.82518588 |
| 79 | Retrobulbar optic neuritis (HP:0100654) | 1.82282604 |
| 80 | Optic neuritis (HP:0100653) | 1.82282604 |
| 81 | Widely patent fontanelles and sutures (HP:0004492) | 1.79629252 |
| 82 | Abnormality of male internal genitalia (HP:0000022) | 1.78563117 |
| 83 | T lymphocytopenia (HP:0005403) | 1.77886943 |
| 84 | Abnormality of the clitoris (HP:0000056) | 1.76220765 |
| 85 | Abnormality of the parietal bone (HP:0002696) | 1.75922799 |
| 86 | Congenital hepatic fibrosis (HP:0002612) | 1.75216408 |
| 87 | Hyperglycinuria (HP:0003108) | 1.74891665 |
| 88 | Progressive cerebellar ataxia (HP:0002073) | 1.73293766 |
| 89 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.73059839 |
| 90 | Oligohydramnios (HP:0001562) | 1.71681384 |
| 91 | Myositis (HP:0100614) | 1.71421347 |
| 92 | Absent speech (HP:0001344) | 1.70810138 |
| 93 | Tachypnea (HP:0002789) | 1.70567483 |
| 94 | Gonadal dysgenesis (HP:0000133) | 1.70450500 |
| 95 | Male pseudohermaphroditism (HP:0000037) | 1.69376734 |
| 96 | Recurrent viral infections (HP:0004429) | 1.67801681 |
| 97 | Medial flaring of the eyebrow (HP:0010747) | 1.66790432 |
| 98 | Recurrent corneal erosions (HP:0000495) | 1.64066290 |
| 99 | Keratoconus (HP:0000563) | 1.63105187 |
| 100 | Increased corneal curvature (HP:0100692) | 1.63105187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.18476112 |
| 2 | BMPR2 | 4.58734106 |
| 3 | TRIM28 | 4.09380008 |
| 4 | SIK3 | 3.51524358 |
| 5 | MAP4K2 | 3.40043777 |
| 6 | SIK2 | 3.19804581 |
| 7 | TLK1 | 3.19547208 |
| 8 | PINK1 | 2.82518510 |
| 9 | CAMKK2 | 2.14485231 |
| 10 | FRK | 2.12533199 |
| 11 | NEK2 | 2.08446259 |
| 12 | BCR | 1.90738245 |
| 13 | ADRBK2 | 1.88869202 |
| 14 | TXK | 1.77920183 |
| 15 | MAP3K7 | 1.71071923 |
| 16 | BCKDK | 1.63980947 |
| 17 | MAP4K1 | 1.60490432 |
| 18 | TAOK3 | 1.57529454 |
| 19 | CCNB1 | 1.55906056 |
| 20 | FLT3 | 1.53654859 |
| 21 | GRK6 | 1.45146839 |
| 22 | MARK3 | 1.44466210 |
| 23 | BTK | 1.35327346 |
| 24 | WNK3 | 1.35028483 |
| 25 | ACVR1B | 1.31936278 |
| 26 | TEC | 1.24242666 |
| 27 | TNIK | 1.22253674 |
| 28 | DAPK2 | 1.20310935 |
| 29 | ERBB3 | 1.17060046 |
| 30 | SYK | 1.16067789 |
| 31 | TNK2 | 1.14484802 |
| 32 | MAPK13 | 1.13262164 |
| 33 | NUAK1 | 1.11817492 |
| 34 | KIT | 1.09968801 |
| 35 | ZAK | 1.06837002 |
| 36 | IRAK4 | 0.98675385 |
| 37 | PDK2 | 0.95297847 |
| 38 | ITK | 0.92582027 |
| 39 | STK11 | 0.92109827 |
| 40 | TAF1 | 0.89906311 |
| 41 | VRK2 | 0.88814300 |
| 42 | CSF1R | 0.84050156 |
| 43 | IKBKE | 0.82009753 |
| 44 | INSRR | 0.80051328 |
| 45 | CAMK1 | 0.79762316 |
| 46 | STK16 | 0.78705818 |
| 47 | BMPR1B | 0.76245471 |
| 48 | CAMK4 | 0.74456409 |
| 49 | WNK4 | 0.72492059 |
| 50 | CSNK1G2 | 0.71216918 |
| 51 | SIK1 | 0.67993002 |
| 52 | MATK | 0.67721830 |
| 53 | STK38L | 0.67641918 |
| 54 | CDK4 | 0.67108282 |
| 55 | MAPKAPK5 | 0.66758845 |
| 56 | PIM1 | 0.66520695 |
| 57 | GRK1 | 0.64982605 |
| 58 | MAP3K11 | 0.61986579 |
| 59 | VRK1 | 0.59536374 |
| 60 | DYRK3 | 0.58738640 |
| 61 | CSNK1G3 | 0.57974386 |
| 62 | OXSR1 | 0.57369632 |
| 63 | ERBB2 | 0.56977971 |
| 64 | MAP2K7 | 0.56722022 |
| 65 | IKBKB | 0.55434376 |
| 66 | PRKAA2 | 0.53994168 |
| 67 | LYN | 0.52061179 |
| 68 | IRAK1 | 0.51985869 |
| 69 | LCK | 0.48011867 |
| 70 | PTK2B | 0.47956921 |
| 71 | CSNK1A1L | 0.47339802 |
| 72 | ATR | 0.46376697 |
| 73 | CAMKK1 | 0.46140453 |
| 74 | DYRK1B | 0.45928352 |
| 75 | HCK | 0.45889542 |
| 76 | TBK1 | 0.43989755 |
| 77 | MAPKAPK3 | 0.43431790 |
| 78 | PRKCE | 0.42931395 |
| 79 | TYK2 | 0.42085319 |
| 80 | PRKCQ | 0.41728056 |
| 81 | ADRBK1 | 0.40738524 |
| 82 | CSNK1G1 | 0.40023266 |
| 83 | PIK3CG | 0.39032972 |
| 84 | BLK | 0.38933301 |
| 85 | PKN1 | 0.38573309 |
| 86 | MAP3K4 | 0.37843023 |
| 87 | PAK3 | 0.37426563 |
| 88 | PRKAA1 | 0.37413126 |
| 89 | MARK2 | 0.35314630 |
| 90 | PRKD2 | 0.34987291 |
| 91 | JAK3 | 0.33595106 |
| 92 | RPS6KA5 | 0.32781885 |
| 93 | GRK5 | 0.32742000 |
| 94 | PRKCI | 0.31879894 |
| 95 | YES1 | 0.30834289 |
| 96 | FES | 0.30597792 |
| 97 | ABL1 | 0.29542139 |
| 98 | IGF1R | 0.29078891 |
| 99 | TRPM7 | 0.27540232 |
| 100 | CHUK | 0.26853460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.91074413 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.21062318 |
| 3 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.68928827 |
| 4 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.41781350 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.36484134 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.35295626 |
| 7 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.30914922 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.23162552 |
| 9 | Phototransduction_Homo sapiens_hsa04744 | 2.19145579 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.14976552 |
| 11 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.09854589 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.96503806 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.92590554 |
| 14 | Basal transcription factors_Homo sapiens_hsa03022 | 1.91464690 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88185436 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.79844665 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.78211786 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68297788 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.65463712 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63663005 |
| 21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.61316989 |
| 22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.51122010 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42961749 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42205382 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.36666615 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.33877060 |
| 27 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.31378732 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.29648049 |
| 29 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.28964493 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.28904235 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28640902 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26802298 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24239088 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.22953651 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.16204046 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12266581 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11970453 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 1.11615523 |
| 39 | Base excision repair_Homo sapiens_hsa03410 | 1.09530092 |
| 40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03678074 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 1.03525244 |
| 42 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.00677742 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 0.99002781 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98952838 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97971007 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93898444 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93208070 |
| 48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92651323 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88409228 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82029745 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 0.79690880 |
| 52 | Long-term depression_Homo sapiens_hsa04730 | 0.79144277 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79074354 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 0.78956884 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77629842 |
| 56 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77361199 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77239138 |
| 58 | Nicotine addiction_Homo sapiens_hsa05033 | 0.72635231 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72066022 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71637931 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.70850466 |
| 62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70553893 |
| 63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70547371 |
| 64 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.70036334 |
| 65 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69479385 |
| 66 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.68574227 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67570767 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67512771 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65036413 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64451218 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.61614527 |
| 72 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59544715 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58391092 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57606200 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56007799 |
| 76 | RNA polymerase_Homo sapiens_hsa03020 | 0.55728568 |
| 77 | Taste transduction_Homo sapiens_hsa04742 | 0.54847495 |
| 78 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.53974297 |
| 79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53799357 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53233526 |
| 81 | Salivary secretion_Homo sapiens_hsa04970 | 0.52942596 |
| 82 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.49589652 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.48641252 |
| 84 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.46778790 |
| 85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46093493 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44657075 |
| 87 | GABAergic synapse_Homo sapiens_hsa04727 | 0.44512508 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44508019 |
| 89 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43970307 |
| 90 | Circadian entrainment_Homo sapiens_hsa04713 | 0.43664684 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41366981 |
| 92 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41001402 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40937186 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39326580 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39200295 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38831909 |
| 97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38067437 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37200507 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34967808 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.34630705 |

